Consortium structure and expertise


The TECHNOBEAT consortium is particularly well-equipped to significantly impact on the enormous challenges ahead in hiPSC-based cell therapies, as it gathers a unique interdisciplinary network of renowned stem cell scientists, clinicians, and engineers covering all fields of competences relevant to the work plan. The readily available framework of hands-on expertise ensures immediate project initiation, fast parallel progress in all WPs and, consequently, the high likelihood to achieve the ambitious goals and timelines.


Adding to its biomedical and technical expertise, the network provides a unique balance of academics, innovation driven SMEs and established industry partners from Germany, Netherlands, Great Britain, Israel, Austria and Belgium. This composition will drive the direct exploitation and commercialisation of project-born tools and technologies, thereby strengthening the competitiveness and growth of the participating companies and deliver innovation to the European biomedical sector.